EICHORPublic-registry site landscape for NCT02129673, “A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension”, a Open Angle Glaucoma study sponsored by ViSci Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02129673 (registry record) |
| Study title | A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
| Official title | A Phase 1/2 Multicenter, Randomized, Controlled Dose-Finding Study to Evaluate the Safety and Ocular Hypotensive Efficacy of 3 Dose Levels of the VS101 Subconjunctival Latanoprost Insert for 3 Months in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
| Sponsor | ViSci Ltd. |
| Condition(s) | Open Angle Glaucoma; Ocular Hypertension |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT02129673.
Eichor generates a preliminary site-risk snapshot for NCT02129673 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Open Angle Glaucoma trials
← Eichor home · All tracked trials · Open Angle Glaucoma studies · Weekly briefs
